Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results. Article

Glass, Jon, Won, Minhee, Schultz, Christopher J et al. (2013). Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results. . JOURNAL OF CLINICAL ONCOLOGY, 31(15_suppl), 2033-2033. 10.1200/jco.2013.31.15_suppl.2033

cited authors

  • Glass, Jon; Won, Minhee; Schultz, Christopher J; Brat, Daniel; Bartlett, Nancy; Suh, John H; Fisher, Barbara Jean; Liepman, Marcia K; Mehta, Minesh P

authors

publication date

  • May 20, 2013

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • 6.5 Radiotherapy and other non-invasive therapies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Hematology
  • Lymphoma
  • Neurosciences
  • Patient Safety
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2033

end page

  • 2033

volume

  • 31

issue

  • 15_suppl